Skip to main content
Premium Trial:

Request an Annual Quote

Genome Research Papers Describe New Coding Sequences, Mitochondrial Copy Number Method, More

Researchers from the European Bioinformatics Institute, Broad Institute, and elsewhere identify previously unappreciated protein-coding using a "Phylogenetic Codon Substitution Frequencies" (PhyloCSF) tool that takes into account evolutionary and sequence conservation clues by lining up genome sequences from several species. Using human, mouse, chicken, fly, worm, and mosquito genome sequences — together with machine learning approaches — the team tracked down and curated dozens of protein-coding genes, along with additional conserved coding sequences and pseudogenes. After lining these genes up against parts of the human genome implicated in prior genome-wide association studies, the authors suggested at least 188 disease-related variants might fall in protein-coding sequences rather than non-coding parts of the genome as previously thought. Based on these and other results, they suggest "PhyloCSF datasets and algorithms will help researchers seeking to interpret these genomes, while our new annotations present exciting loci for further experimental characterization."

A UT Southwestern Medical Center team outlines a droplet digital PCR-based assay it came up with to quantify mitochondrial DNA copy number in individual cells. The high-throughput "droplet digital mitochondrial DNA measurement" (ddMDM) approach makes it possible to discern mtDNA copy number in bulk cell samples or single cells using 96-well plates, the researchers say, adding that it can reportedly produce data from cell lysates without purification steps within a few hours. "ddMDM may be useful for epidemiologic studies, clinical monitoring of mitochondrial diseases, and for much needed studies aimed at understanding the contribution that mtDNA plays in aging and disease," they write, "not only for its role in metabolism but also as a signaling molecule." 

Finally, investigators at Stanford University, McGill University, and the University of Montreal present a strategy for teasing gene expression information out of individual cells in formalin-fixed, paraffin-embedded (FFPE) tissue samples using a combination of laser-capture microdissection and Smart-3SEQ. The latter protocol builds on and combines features from earlier RNA sequencing and single-cell RNA-seq methods, the team explains, using targeted sequence tags to quantify transcripts in small or degraded samples. "[S]mart-3SEQ's compatibility with FFPE tissue unlocks an enormous number of archived clinical samples," authors of that paper suggest, "and combined with [laser-capture microdissection], it allows unprecedented studies of small cell populations and single cells isolated by their in situ context."

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.